Related Experiment Video
Updated: Apr 8, 2026

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
[Malaria and HIV: which interactions?]
People with HIV (PLHIV) face increased severe malaria risk when traveling. Early diagnosis and artemisinin treatments are crucial for successful outcomes in returning travelers.
Area of Science:
- * Infectious Diseases
- * Tropical Medicine
- * Public Health
Background:
- * Individuals living with HIV (PLHIV) frequently travel, posing a risk of Plasmodium infection (malaria).
- * HIV-malaria co-infection exacerbates malaria severity, directly correlating with immunosuppression levels.
- * Pre-travel consultations are less common among PLHIV compared to the general population.
Observation:
- * PLHIV traveling to malaria-endemic regions require specific preventive measures.
- * Recommendations include mosquito bite prevention and antimalarial drug prophylaxis.
- * A notable gap exists in pre-travel health consultations for PLHIV.
Findings:
- * HIV-malaria co-infection significantly elevates the risk of severe malaria.
- * The degree of immunosuppression in PLHIV is a key factor in malaria severity.
- * Early diagnosis and artemisinin-based therapies are critical for treating malaria in returning travelers.
Implications:
- * Targeted travel health advice and interventions are essential for PLHIV.
- * Enhancing pre-travel consultation uptake among PLHIV is a public health priority.
- * Prompt and appropriate treatment is vital for improving malaria outcomes in this vulnerable population.
More Related Videos
08:14An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Sexually Transmitted Infections
Retrovirus Life Cycles
Pharmacokinetics: Drug–Drug Interactions
Diversity of Protists II
Symbiosis